Scholars Central

Research articlePublished 2019

Effect of Atorvastatin on Lung Apoptosis-Associated Protein Caspase-12 in Chronic Obstructive Pulmonary Disease (COPD) Model Rats

Authors: Li-Le Wang, Chun-Chu Kong, Yun-Rong Chen, Dai-Yan Fu, Jie Li, Chang-Yu Huang, Gui-Xiang Gan, Bin-Bin Chen, Mo Liang, Ming Xu, Rui-Cheng Hu, Shuang-Xiang Tan, Ai-guo Dai

Journal of Anesthesiology and Pain Research

Volume 2 · Issue 1 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Abstract Objective: To determine the effect of atorvastatin on the expression of lung apoptosis-associated protein caspase-12 in Chronic Obstructive Pulmonary Disease (COPD) model rats. Methods: 30 rats were randomly divided into three groups: the normal group, the control group, and the treatment group. The control group and the treatment group were treated by being exposed to smoking and intratracheal instillation of lipopolysaccharide to establish the COPD model rats. 2 weeks later, the treatment group was treated with 2.5 mg/kg atorvastatin daily for 6 weeks. Nothing was done in the normal group. The rats were executed after 8 weeks. Lung tissue sections stained by Hematoxylin and Eosin (HE) were observed. The protein and gene expression of lung apoptosis-associated caspase-12 in each group was investigated by RT-PCR and immunohistochemistry. Results: Pulmonary histopathology: emphysema and airway inflammation were observed in the control group, and the symptoms of the treatment group were lighter. RT-PCR: compared with the normal group, a higher level of caspase-12 mRNA was expressed in the control group and the treatment group (p<0.05); compared with the control group, lower level of caspase-12 mRNA was expressed in the treatment group (p<0.05). Immunohistochemistry: compared with the normal group, the expression of caspase-12 increased in the control group and the treatment group (p<0.05). Compared with the control group, the expression of caspase-12 decreased (p<0.05). Conclusion: Atorvastatin has a protective effect on the COPD model rats by decreasing the protein and gene expression of caspase-12 which can reduce the apoptosis of COPD lung tissue.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Anesthesiology and Pain Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Anesthesiology and Pain Research
  • SubjectAnaesthesia & Pain
  • BylineArticles whose byline prints “Li-Le Wang”
  • BylineArticles whose byline prints “Chun-Chu Kong”
  • BylineArticles whose byline prints “Yun-Rong Chen”
  • BylineArticles whose byline prints “Dai-Yan Fu”
  • BylineArticles whose byline prints “Jie Li”
  • BylineArticles whose byline prints “Chang-Yu Huang”
  • BylineArticles whose byline prints “Gui-Xiang Gan”
  • BylineArticles whose byline prints “Bin-Bin Chen”